By Product
- Diagnostic Kits
- Vaccines
- Inactivated Vaccines
- Conjugate Vaccines
- Live Attenuated
- Toxoid Vaccines
- Antiserums and Antibodies
- Immunomodulators
- Others
By Animal Type
- Companion Animals
- Livestock Animals
By Disease Type
- Foot & Mouth Disease
- Tuberculosis and Brucellosis
- Bluetongue
- Others
By Distribution Channel
- Veterinary Clinics
- Veterinary Hospitals
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
The market is categorised into product, animal type, disease type, distribution channel and region. The product segment is diversified into diagnostic kits, vaccines, antiserums and antibodies, immunomodulators and others. The vaccines segment is predicted to hold the largest veterinary biologics market share owing to technological advancements in vaccine development along with consistent resistance of drugs by pathogens. Furthermore, the development of veterinary vaccines has preclinical trial requirements and non-stringent regulations. Thus, emerging market players have the opportunity of entering the market with advanced product developments. The animal type segment is classified into companion animals and livestock animals. Veterinary biologics are mainly used on livestock animals which is the reason this segment is predicted to lead the market during the forecast period. The disease type segment is fragmented into foot & mouth disease, tuberculosis and brucellosis, bluetongue and others. The distribution channel segment is diversified into veterinary clinics, veterinary hospitals and others. The veterinary hospitals segment is predicted to lead the market owing to bolstering governmental support along with the provision of all veterinary treatments.
The North America region subjugated the market due to rising issues regarding pet healthcare and high product costs. Favourable support from the government for developing novel biologic drugs is predicted to boost the market in the European region. The Biotechnology and Biological Sciences Research Council, in December 2015, funded over 5 million GBP for developing poultry vaccines to the London School of Tropical Medicine and Hygiene. Mandates in government necessities for animal immunization, increasing demand for zoonotic and rising ownership of companion animals are some of the veterinary biologics market trends in the Asia Pacific region.